IL87679A0 - (substituted alkylidene)-1,2,3,4-tetrahydro-9-acridinamines,a process for their preparation and pharmaceutical compositions containing same - Google Patents

(substituted alkylidene)-1,2,3,4-tetrahydro-9-acridinamines,a process for their preparation and pharmaceutical compositions containing same

Info

Publication number
IL87679A0
IL87679A0 IL87679A IL8767988A IL87679A0 IL 87679 A0 IL87679 A0 IL 87679A0 IL 87679 A IL87679 A IL 87679A IL 8767988 A IL8767988 A IL 8767988A IL 87679 A0 IL87679 A0 IL 87679A0
Authority
IL
Israel
Prior art keywords
acridinamines
tetrahydro
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL87679A
Other languages
English (en)
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL87679A0 publication Critical patent/IL87679A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL87679A 1987-09-08 1988-09-06 (substituted alkylidene)-1,2,3,4-tetrahydro-9-acridinamines,a process for their preparation and pharmaceutical compositions containing same IL87679A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9393587A 1987-09-08 1987-09-08
US07/223,846 US5013741A (en) 1987-09-08 1988-07-25 N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal

Publications (1)

Publication Number Publication Date
IL87679A0 true IL87679A0 (en) 1989-02-28

Family

ID=26788073

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87679A IL87679A0 (en) 1987-09-08 1988-09-06 (substituted alkylidene)-1,2,3,4-tetrahydro-9-acridinamines,a process for their preparation and pharmaceutical compositions containing same

Country Status (16)

Country Link
US (1) US5013741A (fr)
EP (1) EP0306825B1 (fr)
JP (1) JP2641915B2 (fr)
KR (1) KR890005058A (fr)
AU (1) AU620043B2 (fr)
CA (1) CA1334669C (fr)
DE (1) DE3889043T2 (fr)
DK (1) DK167251B1 (fr)
ES (1) ES2053652T3 (fr)
FI (1) FI89478C (fr)
HU (1) HU201017B (fr)
IE (1) IE63027B1 (fr)
IL (1) IL87679A0 (fr)
NO (1) NO883986L (fr)
NZ (1) NZ226054A (fr)
PT (1) PT88444B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868177A (en) * 1988-11-09 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. 1,2,3,4-tetrahydro-1,9-acridinediamines, pharmaceutical compositions and use
AU621416B2 (en) * 1988-11-16 1992-03-12 Hoechst Marion Roussel, Inc. Hydroxy-1,2,3,4-tetrahydroaminoacridines, a process for their preparation and their use as medicaments
US5175172A (en) * 1988-12-19 1992-12-29 Francois Dietlin Method of alleviating AIDS symptoms and compositions therefor
FR2640508B1 (fr) * 1988-12-19 1994-07-01 Dietlin Francois Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire
US5149813A (en) * 1989-06-26 1992-09-22 Hoechst-Roussel Pharmaceuticals Incorporated Process for (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds
JPH09500645A (ja) * 1993-07-22 1997-01-21 ワーナー−ランバート・コンパニー 制御放出タクリン薬物送達システムおよびその製造方法
CN108047202B (zh) * 2017-12-20 2021-06-11 东南大学 一种铝离子响应型化合物及其制备方法与应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232945A (en) * 1962-08-13 1966-02-01 S E Massengill Company 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines
US3318895A (en) * 1963-12-05 1967-05-09 Squibb & Sons Inc Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines
US3318896A (en) * 1963-12-05 1967-05-09 Squibb & Sons Inc Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines
BE658695A (fr) * 1964-02-03 1965-07-22
US3541066A (en) * 1968-09-16 1970-11-17 American Home Prod 2,3-dihydro-1,4-ethanobenzo(b)(1,5)naphthyridine derivatives
US3580915A (en) * 1968-09-16 1971-05-25 American Home Prod 1,2,3,4-tetrahydrobenzol(b)(1,6)naphthyridine derivatives
US3647800A (en) * 1970-04-30 1972-03-07 American Home Prod 10-substituted - 1 2 3 4 - tetrahydrobenzo(b)(1 6)naphthyridines useful as cns depressants
US3637706A (en) * 1970-04-30 1972-01-25 American Home Prod 10-(4 - (lower)alkylpiperazino) - 1 2 3 4-tetrahydrobenzo(b)(1 6) naphthyridine derivatives useful as cns depressants
US3657233A (en) * 1970-04-30 1972-04-18 American Home Prod 10-morpholino-1 2 3 4-tetrahydrobenzo(b)(1 6)naphthyridine derivatives
US3674790A (en) * 1970-05-01 1972-07-04 American Home Prod 2,10-disubstituted-1,2,3,4-tetrahydrobenzo(bhq (1,6)naphthyridines useful as cns depressants
ES431307A1 (es) * 1973-11-16 1976-09-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos derivados de quinoleina.
US4108998A (en) * 1976-11-08 1978-08-22 American Home Products Corp. Furo[3,4-b]quinoline derivatives and pharmaceutical compositions and methods employing them
US4575553A (en) * 1984-06-18 1986-03-11 Bristol-Myers Company Antitumor m-AMSA analog
DE3582995D1 (de) * 1984-10-25 1991-07-04 Hoechst Roussel Pharma 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
US4631286A (en) * 1984-10-25 1986-12-23 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US4816456A (en) * 1986-10-01 1989-03-28 Summers William K Administration of monoamine acridines in cholinergic neuronal deficit states
DK569087A (da) * 1986-10-31 1988-05-01 Sumitomo Pharma Quinolin-derivater, deres fremstilling og anvendelse
US4762841A (en) * 1987-03-30 1988-08-09 Hoechst-Roussel Pharmaceuticals Inc. Substituted 9-amino-spiro(cycloalkyl(b)quinoline-2,1'cycloalkanes)
US4851536A (en) * 1987-05-07 1989-07-25 American Home Products Corporation Cyclohexylquinolines as inhibitors of interleukin 1
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
WO1989002739A1 (fr) * 1987-10-05 1989-04-06 Pfizer Inc. Derives de 4-aminopyridine
EP0319429B1 (fr) * 1987-12-03 1994-04-27 Mitsubishi Kasei Corporation Dérivés de la 9-(acylamino)tétrahydroacridine et agents pour l'amélioration de la mémoire les contenant comme ingrédient

Also Published As

Publication number Publication date
FI884104A (fi) 1989-03-09
NZ226054A (en) 1991-08-27
DK497888A (da) 1989-03-09
FI89478B (fi) 1993-06-30
JPH01131160A (ja) 1989-05-24
NO883986L (no) 1989-03-09
DE3889043T2 (de) 1994-10-06
EP0306825B1 (fr) 1994-04-13
DE3889043D1 (de) 1994-05-19
ES2053652T3 (es) 1994-08-01
AU620043B2 (en) 1992-02-13
CA1334669C (fr) 1995-03-07
HU201017B (en) 1990-09-28
HUT49332A (en) 1989-09-28
KR890005058A (ko) 1989-05-11
FI884104A0 (fi) 1988-09-06
IE63027B1 (en) 1995-03-22
DK497888D0 (da) 1988-09-07
JP2641915B2 (ja) 1997-08-20
DK167251B1 (da) 1993-09-27
AU2193688A (en) 1989-03-09
US5013741A (en) 1991-05-07
PT88444B (pt) 1992-10-30
FI89478C (fi) 1993-10-11
EP0306825A1 (fr) 1989-03-15
PT88444A (pt) 1989-07-31
NO883986D0 (no) 1988-09-07
IE882703L (en) 1989-03-08

Similar Documents

Publication Publication Date Title
IL85741A0 (en) Substituted 9-amino-tetrahydroacridines and related compounds,a process for their preparation and pharmaceutical compositions containing them
IL93423A0 (en) Piperidine compounds,their preparation and pharmaceutical compositions containing them
IL88156A0 (en) Azacyclic compounds,their preparation and pharmaceutical compositions containing them
GR900300002T1 (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
IL84944A (en) Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation
IL86798A (en) 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them
IL88184A0 (en) Tetrahydropyridine derivatives,their preparation and pharmaceutical compositions containing them
ZA899434B (en) 9-a2a-3-(oxa-thia)-biocyclo 3,2,1 nonane derivatives,process intermediates for their preparation and pharmaceutical compositions containing them
IL90864A0 (en) Substituted 1,7-annelated 1h-indazoles,their preparation and pharmaceutical compositions containing them
HUT48248A (en) Process for producing 3,7-diazabicyclo/3,3,1/-nonan derivatives and pharmaceutical compositions containing them
ZA89894B (en) Perhydrocycloalka(1,2-a)imadazone-2,5-diones,process for their preparation and pharmaceutical compositions containing them
IL84841A (en) 2,3-disubstituted isoxazolidines,a process for their preparation,and pharmaceutical compositions containing them
IL85290A0 (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation and pharmaceutical compositions containing same
IL83413A0 (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL86027A (en) 2-acylpyrrolidine derivatives,a process for the preparation thereof,compositions containing them,and their use
IL88002A0 (en) 2,2-dimethylchromene derivatives,their preparation and pharmaceutical compositions containing them
IL87679A0 (en) (substituted alkylidene)-1,2,3,4-tetrahydro-9-acridinamines,a process for their preparation and pharmaceutical compositions containing same
IL88827A (en) 5,5-dimethyl-3-styryl -2-cyclohexene-1-one oxime derivatives, their preparation and pharmaceutical compositions containing them
EP0236929A3 (en) 1,2-dithiol-3-thione derivatives, a process for preparing them and a pharmaceutical composition containing them
IL87016A (en) Phenylpiperidine derivatives, their preparation and pharmaceutical compositions containing them
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
IL82294A0 (en) 1,3-dihydropyridine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IL85612A0 (en) 4-phenylpiperidine compounds,their preparation and pharmaceutical compositions containing them
IL91737A0 (en) 2,7-diamino-1,2,3,4-tetrahydro-naphthalenes,their preparation and pharmaceutical compositions containing them
IL92289A0 (en) 1-aminoalkyl-3-oxysubstituted 4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepine-2-ones,a process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
RH1 Patent not in force